Higher busulfan dose intensity appears to improve leukemia-free and overall survival in AML allografted in CR2: An analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation
2011 ◽
Vol 17
(1)
◽
pp. 78-85
◽
2015 ◽
Vol 90
(8)
◽
pp. 719-724
◽
2021 ◽
Vol 27
(3)
◽
pp. S136-S137